| Literature DB >> 35223636 |
Hasti Kamali Sarvestani1, Roshanak Daie Ghazvini1, Seyed Jamal Hashemi1,2, Mohsen Gerami Shoar1, Saham Ansari3, Zahra Rafat4, Aslan Ahmadi5, Pedram Borghei6, Miad Elahi6, Abbas Rahimi Foroushani7, Muhammad Ibrahim Getso1,8, Shima Aboutalebian9, Fatemeh Safari10, Pegah Ardi1.
Abstract
BACKGROUND: Tracheoesophageal voice prostheses (TVPs) have been the gold standard in rehabilitation, after laryngectomy, producing faster and premier voicing towards esophageal speech. Fungal colonization shortens the device's lifetime and leads to prosthesis dysfunction, leakage, and subsequent respiratory infection. Therefore, in the current study, we aimed to investigate the fungal colonization patterns and to propose prophylactic measures that shall increase the longevity of voice prosthesis.Entities:
Keywords: Antifungal susceptibility test; Candida; Fungal colonization; Voice prostheses
Year: 2022 PMID: 35223636 PMCID: PMC8837888 DOI: 10.18502/ijph.v51i1.8306
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
The distribution of 66 patients with leakage through the tracheoesophageal voice prostheses based on their gender in different age groups
|
|
|
| |||||
|---|---|---|---|---|---|---|---|
|
| |||||||
| 32–42 | 43–53 | 54–64 | 65–75 | 75–85 | >85 | ||
| Male | 2 (3.03) | 7 (10.60) | 19 (28.78) | 22 (33.33) | 4 (6.06) | 1 (1.51) | |
| Female | 2 (3.03) | 2 (3.03) | 2 (3.03) | 3 (4.54) | 1 (1.51) | 0 (0) | |
| Total (n) (%) | - | 4 (6.06) | 9 (13.63) | 21 (31.81) | 25 (37.87) | 5 (7.57) | 1 (1.51) |
Underlying diseases and predisposing factors of total laryngectomy patients
|
|
|
|---|---|
| Tobacco smoker | 98 |
| Alcohol intemperance | 38 |
| Diabetes mellitus | 31 |
| HIV positive | 2 |
Distribution of the colony colors within each yeast species using CHROMagar Candida medium
|
|
|
|---|---|
|
| Pink(12) |
| Purple(29) | |
|
| Green (22) |
|
| Pale pink (10) |
| Purple(2) | |
|
| Dark blue (11) |
The spectrum of isolated fungi from 66 failed tracheoesophageal voice prostheses
|
|
|
|
|---|---|---|
|
| 25 | 31.7 |
|
| 19 | 24 |
|
| 18 | 22.8 |
|
| 13 | 16.5 |
|
| 2 | 2.5 |
|
| 2 | 2.5 |
| Total | 79 | 100 |
The geometric mean, MIC ranges, MIC50 and MIC90 values obtained by testing the susceptibility of 79 Candida spp. and Geotrichum isolates to the antifungal agents and vinegar
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| FLC | 23.35 | 8–32 | 16 | 64 | |
| FLC/V | 1.28, 0.08 | 0.25–0.063/4-1 | 0.063/1 | 0.25/2 | |
| AMB | 1.31 | 1–2 | 1 | 2 | |
| AMB/V
| 0.20/3.31 | 0.25–0.125/4-2 | 0.25/4 | 0.25/4 | |
| NYS | 2.7 | 2–4 | 2 | 4 | |
| NYS/V
| 0.06/0.23 | 0.125–0.063/0.5-0.25 | 0.063/0.25 | 0.063/0.25 | |
| V | 0.5 | 0.5 | 0.5 | 0.5 | |
| FLC | 0.78 | 4–0.125 | 1 | 4 | |
| FLC/V | 0.015/1.07 | 0.032–0.004/4-0.25 | 0.016/1 | 0.032/2 | |
| AMB | 0.97 | 1–2 | 1 | 2 | |
| AMB/V | 0.38/5.2 | 0.5–0.125/8-2 | 0.25/4 | 0.5/8 | |
| NYS | 1.73 | 0.5–4 | 2 | 4 | |
| NYS/V | 0.10/1.21 | 0.125–0.063/2-1 | 0.063/1 | 0.125/2 | |
| V | 0.5 | 0.5 | 0.5 | 0.5 | |
| FLC | 12.66 | 8–16 | 8 | 16 | |
| FLC/V | 9.12/0.19 | 8–16/0.125-0.25 | 8/0.125 | 16/0.25 | |
| AMB | 0.88 | 0.5-2 | 1 | 2 | |
| AMB/V | 1.61/0.11 | 1–4/0.063-0.25 | 1/0.063 | 2/0.125 | |
| NYS | 1.57 | 1–2 | 2 | 2 | |
| NYS/V | 1.74/0.08 | 1–2/0.063-0.125 | 2/0.063 | 2/0.125 | |
| V | 0.25 | 0.25 | 0.25 | 0.25 | |
| FLC | 7.88 | 4–16 | 8 | 16 | |
| FLC/V | 6.27/0.125 | 4–16/0.063-0.25 | 8/0.125 | 16/0.25 | |
| AMB | 1.08 | 0.5–4 | 1 | 2 | |
| AMB/V | 2/0.125 | 2/0.063–0.25 | 1/0.125 | 2/0.25 | |
| NYS | 1.41 | 0.5–2 | 1 | 2 | |
| NYS/V | 1.24/0.09 | 0.5–2/0.063-0.25 | 1/0.125 | 2/0.25 | |
| V | 0.5 | 0.5 | 0.5 | 0.5 | |
| FLC | 4 | 4 | |||
| FLC/V | 8/0.125 | 8/0.125 | |||
| AMB | 1 | 1 | |||
| AMB/V | 4/0.25 | 4/0.25 | |||
| NYS | 4 | 4 | |||
| NYS/V | 4/0.125 | 4/0.125 | |||
| V | 0.5 | 0.5 | |||
| FLC | 16 | 16 | |||
| FLC/V | 8/0.125 | 8/0.125 | |||
| AMB | 0.5 | 0.5 | |||
| AMB/V | 2/0.125 | 2/0.125 | |||
| NYS | 8 | 8 | |||
| NYS/V | 4/0.125 | 4/0.125 | |||
| V | 0.5 | 0.5 |
GM: Geometric mean;
MIC: Minimum inhibitory concentration;
MIC50: minimal concentration that inhibits 50% of isolates;
MIC90: minimal concentration that inhibits 90% of isolates;
FLC: Fluconazole,
V: Vinegar;
AMB: Amphotericin B,
NYS: Nystatin,
FLC/V: combination of fluconazole and vinegar,
AMB/V: combination of amphotericin B and vinegar,
NYS/V: combination of nystatin and vinegar